Damian Gumpel Buys 7,822 Shares of The Chemours Company (NYSE:CC) Stock

The Chemours Company (NYSE:CC - Get Free Report) insider Damian Gumpel bought 7,822 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was bought at an average price of $9.95 per share, with a total value of $77,828.90. Following the acquisition, the insider now owns 131,701 shares in the company, valued at approximately $1,310,424.95. This represents a 6.31% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Chemours Price Performance

NYSE:CC traded up $0.12 during mid-day trading on Wednesday, hitting $10.05. 3,041,422 shares of the company's stock traded hands, compared to its average volume of 2,180,616. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The firm's 50 day simple moving average is $11.37 and its 200 day simple moving average is $15.52. The Chemours Company has a 1 year low of $9.13 and a 1 year high of $25.80. The company has a market cap of $1.50 billion, a PE ratio of 17.63 and a beta of 1.76.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 26.54% and a net margin of 1.51%. The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the prior year, the business earned $0.32 earnings per share. Chemours's revenue for the quarter was up .4% on a year-over-year basis. Sell-side analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The company also recently declared a dividend, which will be paid on Monday, June 16th. Shareholders of record on Monday, May 19th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, May 16th. This represents a dividend yield of 3.17%. Chemours's dividend payout ratio is currently 175.00%.

Analyst Upgrades and Downgrades

CC has been the subject of a number of recent research reports. Truist Financial decreased their price target on shares of Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Wall Street Zen downgraded shares of Chemours from a "hold" rating to a "sell" rating in a report on Wednesday, May 21st. Royal Bank of Canada cut their price target on shares of Chemours from $17.00 to $14.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Morgan Stanley cut their price target on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a report on Monday, May 12th. Finally, UBS Group cut their price target on shares of Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $17.22.

Institutional Investors Weigh In On Chemours

Several hedge funds have recently modified their holdings of CC. Barclays PLC boosted its stake in shares of Chemours by 28.4% during the 3rd quarter. Barclays PLC now owns 107,549 shares of the specialty chemicals company's stock worth $2,185,000 after purchasing an additional 23,766 shares during the last quarter. KBC Group NV boosted its stake in shares of Chemours by 38.2% during the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock worth $104,000 after purchasing an additional 1,708 shares during the last quarter. ARGA Investment Management LP boosted its position in shares of Chemours by 0.7% in the fourth quarter. ARGA Investment Management LP now owns 148,614 shares of the specialty chemicals company's stock worth $2,512,000 after acquiring an additional 1,032 shares during the last quarter. Strategic Financial Concepts LLC acquired a new stake in shares of Chemours in the fourth quarter worth approximately $357,000. Finally, Entropy Technologies LP acquired a new stake in shares of Chemours during the 4th quarter worth $266,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.